Integrated In Vitro Models - Digestion, Mucus permeation and Epithelial absorption.
Aelius Biotech has raised $955K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Aelius Biotech's investors include Innovate UK, North East Fund.
Aelius Biotech is headquartered in Newcastle, United Kingdom.
Integrated In Vitro Models - Digestion, Mucus permeation and Epithelial absorption.
Aelius Biotech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aelius Biotech — Funding & Investors." VCBacked, April 7, 2025, https://www.vcbacked.co/company/aelius-biotech. Accessed September 30, 2026.
VCBacked. (2025). Aelius Biotech — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/aelius-biotech
{{cite web |title=Aelius Biotech — Funding & Investors |url=https://www.vcbacked.co/company/aelius-biotech |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated